Home/ Supplements/ Omega 3/ Omega PhytoCan

Omega PhytoCan

product on market Softgel Capsule Allergy Research Group Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 22% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Fish oil provides omega-3 fatty acids, which have strong evidence for supporting cardiovascular health and reducing systemic inflammation. Research indicates these nutrients contribute to cognitive function and joint maintenance. The evidence coverage for this specific profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega PhytoCan
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
22%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1 Gram(s) (1% DV)
Cholesterol
5 mg (2% DV)
740 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Gamma-Linolenic Acid
50 mg
Oleic Acid
35 mg
100 mg
Market median: 35.0mg (257 products)
Sunflower Lecithin
100 mg

Other Ingredients

Gelatin Glycerin purified Water natural Lemon flavor Mixed Tocopherols Rosemary extract Ascorbyl Palmitate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use As a dietary supplement, 1 softgel daily with food, or as directed by a healthcare practitioner.

Formulation Notes

Full spectrum essential fatty acids, including EPA, DHA, GLA, and unmodified hemp oil with naturally occurring phytocannabinoids, enhanced with sunflower lecithin.

Full-spectrum EFA-Phytocannabinoids

Metadata

Product Details

UPC / SKU7 13947 77350 9
DSLD Entry Date2020-08-23
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID233315
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.